CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The TEMPLe project aims to enhance the prediction of clinical outcomes in Chronic Lymphocytic Leukaemia by integrating epigenetic variables into personalized risk scores. By developing a digital platform for risk assessment, the project seeks to improve patient management and potentially extend its approach to other ca…
Predicting the future clinical behaviour of a patient’s cancer remains a major scientific and clinical challenge.
Chronic Lymphocytic Leukaemia (CLL), the most common leukaemia in the Western world, exhibits a broad range of clinical behaviours.
The disease begins with a premalignant state that can later progress into an asymptomatic, progressive and highly aggressive form with a poor prognosis.
Predicting the risk and timing of progression is a major unmet clinical need in CLL.
Through our ERC-…
FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
